Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Pharmacokinetics of (/sup 14/C)teicoplanin in male rats after single intravenous dose

Journal Article · · Antimicrob. Agents Chemother.; (United States)
DOI:https://doi.org/10.1128/AAC.30.5.733· OSTI ID:6802750

The pharmacokinetic profile of (/sup 14/C)teicoplanin was studied in male Sprague-Dawley rats given a single 10,000-U/kg intravenous dose. The disposition of the antimicrobial activity in the body was estimated by a three-compartment open model. Plasma concentration data were fitted to a three-exponent equation. The profile of total /sup 14/C in plasma was similar to that of the microbiological activity. The cumulative recovery of total /sup 14/C 5 days after drug administration averaged 76.3% of the administered dose in the urine and 8.7% in the feces. The residual dose remaining in the animal carcasses was 11.1%. Teicoplanin was widely distributed in the body. In almost all organs, the maximum concentration of (/sup 14/C)teicoplanin was already reached at the first time of killing, which was 0.25 h after the administration of drug. The liver, kidneys, skin, and fat contained most of the residual dose found in the animal carcasses 120 h after administration and behaved as a deep compartment with the adrenal glands and spleen.

Research Organization:
Lepetit Research Center, Gruppo Lepetit S.p.A., Milan, Italy
OSTI ID:
6802750
Journal Information:
Antimicrob. Agents Chemother.; (United States), Journal Name: Antimicrob. Agents Chemother.; (United States) Vol. 5; ISSN AMACC
Country of Publication:
United States
Language:
English